Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- Incidence of AL Amyloidosis in Olmsted County, Minnesota, 1990 through 2015.Mayo Clin Proc. 2019; 94: 465-471
- Epidemiology of AL amyloidosis: a real-world study using US claims data.Blood Adv. 2018; 2: 1046-1053
- Technetium pyrophosphate uptake in transthyretin cardiac amyloidosis: Associations with echocardiographic disease severity and outcomes.J Nucl Cardiol. 2018; 25: 1247-1256
- Amyloid heart disease: genetics translated into disease-modifying therapy.Heart Br Card Soc. 2017; 103: 812-817
HCUP National (Nationwide) Inpatient Sample (NIS). Healthcare Cost and Utilization Project (HCUP). Available at: http://www.hcup-us.ahrq.gov/nisoverview.jsp. Accessed 19 November 2018.
- Comorbidity measures for use with administrative data.Med Care. 1998; 36: 8-27
- Prevalence of monoclonal gammopathy of undetermined significance.N Engl J Med. 2006; 354: 1362-1369
- A long-term study of prognosis in monoclonal gammopathy of undetermined significance.N Engl J Med. 2002; 346: 564-569
- Incidence and natural history of primary systemic amyloidosis in Olmsted County, Minnesota, 1950 through 1989.Blood. 1992; 79: 1817-1822
- The Amyloidogenic V122I transthyretin variant in elderly black Americans.N Engl J Med. 2015; 372: 21-29
- Estimating the global prevalence of transthyretin familial amyloid polyneuropathy.Muscle Nerve. 2018; 57: 829-837
- Senile systemic amyloidosis affects 25% of the very aged and associates with genetic variation in alpha2-macroglobulin and tau: a population-based autopsy study.Ann Med. 2008; 40: 232-239
- Geographic disparities in reported US amyloidosis mortality from 1979 to 2015: potential underdetection of cardiac amyloidosis.JAMA Cardiol. 2018; 3: 865-870
- Tenosynovial and cardiac amyloidosis in patients undergoing carpal tunnel release.J Am Coll Cardiol. 2018; 72: 2040-2050
- Efficacy of chemotherapy for light-chain amyloidosis in patients presenting with symptomatic heart failure.J Am Coll Cardiol. 2016; 67: 2941-2948
- Systemic immunoglobulin light chain amyloidosis.Nat Rev Dis Primer. 2018; 4: 38
Funding: This work was funded by an ASPIRE grant WI241765 from Pfizer Global Medical Grants.